Board Change • Feb 13
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. No experienced directors. 1 highly experienced director. Chairman of the Board Sumithra Anura Ekanayake is the most experienced director on the board, commencing their role in 2016. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. New Risk • Oct 14
New minor risk - Dividend sustainability The dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 1.4% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (22% accrual ratio). Market cap is less than US$10m (LK₨2.90b market cap, or US$9.58m). Minor Risks Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (12% net profit margin). Revenue is less than US$5m (LK₨930m revenue, or US$3.1m). Valuation Update With 7 Day Price Move • Sep 01
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to LK₨194, the stock trades at a trailing P/E ratio of 29.3x. Average trailing P/E is 10x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 136% over the past three years. New Risk • Aug 13
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 22% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (22% accrual ratio). Market cap is less than US$10m (LK₨2.67b market cap, or US$8.86m). Minor Risks Profit margins are more than 30% lower than last year (12% net profit margin). Revenue is less than US$5m (LK₨930m revenue, or US$3.1m). Valuation Update With 7 Day Price Move • Jun 30
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to LK₨165, the stock trades at a trailing P/E ratio of 22x. Average trailing P/E is 9x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 249% over the past three years. Upcoming Dividend • Jun 24
Upcoming dividend of LK₨2.50 per share Eligible shareholders must have bought the stock before 01 July 2025. Payment date: 21 July 2025. Payout ratio is a comfortable 33% and the cash payout ratio is 80%. Trailing yield: 1.7%. Lower than top quartile of Sri Lankan dividend payers (5.4%). Lower than average of industry peers (4.7%). Declared Dividend • May 29
Dividend of LK₨2.50 announced Dividend of LK₨2.50 is the same as last year. Ex-date: 1st July 2025 Payment date: 21st July 2025 Dividend yield will be 1.6%, which is lower than the industry average of 8.6%. Sustainability & Growth Dividend is covered by both earnings (33% earnings payout ratio) and cash flows (56% cash payout ratio). The dividend has increased by an average of 9.6% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to decline by 63% to shift the payout ratio to a potentially unsustainable range, which is more than the 12% EPS decline seen over the last 5 years. Announcement • May 28
Chemanex PLC announces Annual dividend, payable on July 21, 2025 Chemanex PLC announced Annual dividend of LKR 2.5000 per share payable on July 21, 2025, ex-date on July 01, 2025 and record date on July 02, 2025. Announcement • May 27
Chemanex PLC, Annual General Meeting, Jun 30, 2025 Chemanex PLC, Annual General Meeting, Jun 30, 2025. Reported Earnings • May 24
Full year 2025 earnings released: EPS: LK₨7.48 (vs LK₨7.12 in FY 2024) Full year 2025 results: EPS: LK₨7.48 (up from LK₨7.12 in FY 2024). Revenue: LK₨873.5m (up 11% from FY 2024). Net income: LK₨117.6m (up 5.1% from FY 2024). Profit margin: 14% (in line with FY 2024). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 37% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Feb 17
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to LK₨174, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 8x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 139% over the past three years. Reported Earnings • Jan 21
Third quarter 2025 earnings released: EPS: LK₨1.84 (vs LK₨2.70 in 3Q 2024) Third quarter 2025 results: EPS: LK₨1.84 (down from LK₨2.70 in 3Q 2024). Revenue: LK₨253.4m (up 17% from 3Q 2024). Net income: LK₨29.0m (down 32% from 3Q 2024). Profit margin: 11% (down from 20% in 3Q 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Jan 02
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to LK₨185, the stock trades at a trailing P/E ratio of 18.3x. Average trailing P/E is 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 151% over the past three years. Valuation Update With 7 Day Price Move • Dec 17
Investor sentiment improves as stock rises 26% After last week's 26% share price gain to LK₨123, the stock trades at a trailing P/E ratio of 12.2x. Average trailing P/E is 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 82% over the past three years. New Risk • Nov 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Sri Lankan stocks, typically moving 5.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 8.9% per year over the past 5 years. High level of non-cash earnings (27% accrual ratio). Market cap is less than US$10m (LK₨1.37b market cap, or US$4.71m). Minor Risks Dividend is not well covered by cash flows (382% cash payout ratio). Share price has been volatile over the past 3 months (5.4% average weekly change). Revenue is less than US$5m (LK₨821m revenue, or US$2.8m). Reported Earnings • Oct 25
Second quarter 2025 earnings released: EPS: LK₨1.07 (vs LK₨0.092 loss in 2Q 2024) Second quarter 2025 results: EPS: LK₨1.07 (up from LK₨0.092 loss in 2Q 2024). Revenue: LK₨206.3m (up 12% from 2Q 2024). Net income: LK₨16.8m (up LK₨18.2m from 2Q 2024). Profit margin: 8.1% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 02
First quarter 2025 earnings released: EPS: LK₨2.71 (vs LK₨0.90 in 1Q 2024) First quarter 2025 results: EPS: LK₨2.71 (up from LK₨0.90 in 1Q 2024). Revenue: LK₨173.4m (up 6.1% from 1Q 2024). Net income: LK₨42.5m (up 199% from 1Q 2024). Profit margin: 25% (up from 8.7% in 1Q 2024). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Announcement • May 31
Chemanex PLC, Annual General Meeting, Jun 28, 2024 Chemanex PLC, Annual General Meeting, Jun 28, 2024. Declared Dividend • May 30
Dividend of LK₨2.50 announced Dividend of LK₨2.50 is the same as last year. Ex-date: 1st July 2024 Payment date: 18th July 2024 Dividend yield will be 2.9%, which is lower than the industry average of 8.6%. Sustainability & Growth Dividend is covered by earnings (58% earnings payout ratio) but not covered by cash flows (124% cash payout ratio). The dividend has increased by an average of 9.6% per year over the past 10 years. However, payments have been volatile during that time. Earnings per share has grown by 4.3% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover. Reported Earnings • May 19
Full year 2024 earnings released: EPS: LK₨7.11 (vs LK₨10.82 in FY 2023) Full year 2024 results: EPS: LK₨7.11 (down from LK₨10.82 in FY 2023). Revenue: LK₨789.0m (down 26% from FY 2023). Net income: LK₨111.7m (down 34% from FY 2023). Profit margin: 14% (down from 16% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Apr 30
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to LK₨85.00, the stock trades at a trailing P/E ratio of 19.8x. Average trailing P/E is 6x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 31% over the past three years. Reported Earnings • Jan 18
Third quarter 2024 earnings released: EPS: LK₨2.70 (vs LK₨1.42 in 3Q 2023) Third quarter 2024 results: EPS: LK₨2.70 (up from LK₨1.42 in 3Q 2023). Revenue: LK₨217.5m (down 1.6% from 3Q 2023). Net income: LK₨42.4m (up 90% from 3Q 2023). Profit margin: 20% (up from 10% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 12% per year, which means it is significantly lagging earnings. Reported Earnings • Oct 21
Second quarter 2024 earnings released: LK₨0.092 loss per share (vs LK₨3.36 profit in 2Q 2023) Second quarter 2024 results: LK₨0.092 loss per share (down from LK₨3.36 profit in 2Q 2023). Revenue: LK₨183.8m (down 48% from 2Q 2023). Net loss: LK₨1.40m (down 103% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. New Risk • Jul 28
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Sri Lankan stocks, typically moving 8.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.4% average weekly change). Earnings have declined by 27% per year over the past 5 years. Market cap is less than US$10m (LK₨1.41b market cap, or US$4.29m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (10% net profit margin). Revenue is less than US$5m (LK₨971m revenue, or US$3.0m). Reported Earnings • Jul 21
First quarter 2024 earnings released: EPS: LK₨0.90 (vs LK₨5.25 in 1Q 2023) First quarter 2024 results: EPS: LK₨0.90 (down from LK₨5.25 in 1Q 2023). Revenue: LK₨163.5m (down 36% from 1Q 2023). Net income: LK₨14.2m (down 83% from 1Q 2023). Profit margin: 8.7% (down from 32% in 1Q 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Jun 27
Upcoming dividend of LK₨2.50 per share at 3.6% yield Eligible shareholders must have bought the stock before 04 July 2023. Payment date: 24 July 2023. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 3.6%. Lower than top quartile of Sri Lankan dividend payers (8.4%). Lower than average of industry peers (8.3%). Announcement • Jun 07
Chemanex PLC, Annual General Meeting, Jun 30, 2023 Chemanex PLC, Annual General Meeting, Jun 30, 2023, at 09:30 Sri Lanka Standard Time. Location: 9th Floor, Auditorium of Commercial Bank of Ceylon PLC, No.01, Union Place Colombo 02 Sri Lanka Agenda: To receive and adopt the statements of accounts of the company and of the group for the year ended 31st March 2023 together with the reports of the directors and auditors thereon; to declare a dividend as recommended by the directors; to reappoint Mr. E M M Boyagoda, who attained the age of 70 years on 29th April 2021, by passing the following Resolution of directors in terms of Section 211 of the Companies Act No. 7 of 2007; to reappoint M/s. Ernst & Young, Chartered Accountants as Auditors of the company and to authorise the directors to determine their remuneration; and to vote a sum as donations. Reported Earnings • May 26
Full year 2023 earnings released: EPS: LK₨10.82 (vs LK₨6.20 in FY 2022) Full year 2023 results: EPS: LK₨10.82 (up from LK₨6.20 in FY 2022). Revenue: LK₨1.06b (up 66% from FY 2022). Net income: LK₨169.9m (up 75% from FY 2022). Profit margin: 16% (in line with FY 2022). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 17% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Jan 18
Third quarter 2023 earnings released: EPS: LK₨1.42 (vs LK₨1.52 in 3Q 2022) Third quarter 2023 results: EPS: LK₨1.42 (down from LK₨1.52 in 3Q 2022). Revenue: LK₨221.0m (up 37% from 3Q 2022). Net income: LK₨22.3m (down 6.7% from 3Q 2022). Profit margin: 10% (down from 15% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 10% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Board Change • Dec 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Independent Director Ekanayake Mudiyanselage Boyagoda was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Nov 21
Investor sentiment deteriorated over the past week After last week's 17% share price decline to LK₨62.00, the stock trades at a trailing P/E ratio of 5.1x. Average trailing P/E is 4x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 14% over the past three years. Board Change • Nov 17
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Independent Director Ekanayake Mudiyanselage Boyagoda was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 21
Second quarter 2023 earnings released: EPS: LK₨3.36 (vs LK₨1.37 in 2Q 2022) Second quarter 2023 results: EPS: LK₨3.36 (up from LK₨1.37 in 2Q 2022). Revenue: LK₨351.2m (up 120% from 2Q 2022). Net income: LK₨52.8m (up 147% from 2Q 2022). Profit margin: 15% (up from 13% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 14% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Sep 01
Investor sentiment improved over the past week After last week's 16% share price gain to LK₨89.00, the stock trades at a trailing P/E ratio of 8.8x. Average trailing P/E is 5x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 75% over the past three years. Valuation Update With 7 Day Price Move • Aug 04
Investor sentiment improved over the past week After last week's 22% share price gain to LK₨64.50, the stock trades at a trailing P/E ratio of 6.4x. Average trailing P/E is 5x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 9.5% over the past three years. Reported Earnings • Jul 21
First quarter 2023 earnings released: EPS: LK₨5.25 (vs LK₨1.32 in 1Q 2022) First quarter 2023 results: EPS: LK₨5.25 (up from LK₨1.32 in 1Q 2022). Revenue: LK₨256.4m (up 81% from 1Q 2022). Net income: LK₨82.5m (up 296% from 1Q 2022). Profit margin: 32% (up from 15% in 1Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has only fallen by 3% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Jun 24
Upcoming dividend of LK₨2.00 per share Eligible shareholders must have bought the stock before 01 July 2022. Payment date: 22 July 2022. Payout ratio is a comfortable 32% but the company is not cash flow positive. Trailing yield: 4.0%. Lower than top quartile of Sri Lankan dividend payers (9.4%). Lower than average of industry peers (7.9%). Board Change • Jun 15
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. Non-Executive Independent Director Ekanayake Mudiyanselage Boyagoda was the last director to join the board, commencing their role in 2018. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Jun 04
Chemanex PLC, Annual General Meeting, Jun 30, 2022 Chemanex PLC, Annual General Meeting, Jun 30, 2022, at 09:30 Sri Lanka Standard Time. Location: 199, Kew Road, Colombo 2 Colombo Sri Lanka Agenda: To receive and adopt the Statements of Accounts of the Company and of the Group for the year ended 31st March 2022 together with the Reports of the Directors and Auditors thereon; to consider dividend; to consider re-election of directors; to consider re-appointing M/s. Ernst & Young, Chartered Accountants as Auditors of the Company and to authorize the Directors to determine their remuneration; and to consider such other matters. Reported Earnings • May 23
Full year 2022 earnings released: EPS: LK₨6.20 (vs LK₨1.22 in FY 2021) Full year 2022 results: EPS: LK₨6.20 (up from LK₨1.22 in FY 2021). Revenue: LK₨639.7m (up 45% from FY 2021). Net income: LK₨97.4m (up 409% from FY 2021). Profit margin: 15% (up from 4.3% in FY 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • May 19
Investor sentiment improved over the past week After last week's 15% share price gain to LK₨65.00, the stock trades at a trailing P/E ratio of 14.6x. Average trailing P/E is 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 47% over the past three years. Valuation Update With 7 Day Price Move • Mar 29
Investor sentiment deteriorated over the past week After last week's 17% share price decline to LK₨61.60, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 8x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 11% over the past three years. Reported Earnings • Jan 23
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: LK₨1.52 (up from LK₨0.98 loss in 3Q 2021). Revenue: LK₨161.5m (up 42% from 3Q 2021). Net income: LK₨23.9m (up LK₨39.4m from 3Q 2021). Profit margin: 15% (up from net loss in 3Q 2021). The move to profitability was driven by higher revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 99 percentage points per year, which is a significant difference in performance. Valuation Update With 7 Day Price Move • Jan 21
Investor sentiment improved over the past week After last week's 19% share price gain to LK₨115, the stock trades at a trailing P/E ratio of 59.1x. Average trailing P/E is 11x in the Chemicals industry in Sri Lanka. Total returns to shareholders of 154% over the past three years. Reported Earnings • Oct 23
Second quarter 2022 earnings released: EPS LK₨1.37 (vs LK₨1.21 in 2Q 2021) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2022 results: Revenue: LK₨159.7m (up 19% from 2Q 2021). Net income: LK₨21.4m (up 13% from 2Q 2021). Profit margin: 13% (in line with 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 88 percentage points per year, which is a significant difference in performance. Reported Earnings • Jul 22
First quarter 2022 earnings released: EPS LK₨1.32 (vs LK₨0.74 in 1Q 2021) The company reported a solid first quarter result with improved earnings and revenues, although profit margins were flat. First quarter 2022 results: Revenue: LK₨141.8m (up 69% from 1Q 2021). Net income: LK₨20.8m (up 78% from 1Q 2021). Profit margin: 15% (in line with 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 76 percentage points per year, which is a significant difference in performance. Upcoming Dividend • Jun 25
Upcoming dividend of LK₨1.00 per share Eligible shareholders must have bought the stock before 01 July 2021. Payment date: 22 July 2021. Trailing yield: 1.3%. Lower than top quartile of Sri Lankan dividend payers (5.5%). Lower than average of industry peers (5.0%). Is New 90 Day High Low • Feb 23
New 90-day low: LK₨79.70 The company is down 9.0% from its price of LK₨87.70 on 25 November 2020. The Sri Lankan market is up 26% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 59% over the same period. Is New 90 Day High Low • Jan 27
New 90-day high: LK₨103 The company is up 51% from its price of LK₨67.90 on 29 October 2020. The Sri Lankan market is up 55% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 122% over the same period. Is New 90 Day High Low • Jan 12
New 90-day high: LK₨93.10 The company is up 33% from its price of LK₨69.90 on 14 October 2020. The Sri Lankan market is up 24% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 40% over the same period. Is New 90 Day High Low • Nov 23
New 90-day high: LK₨92.60 The company is up 63% from its price of LK₨56.70 on 25 August 2020. The Sri Lankan market is up 13% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 53% over the same period. Valuation Update With 7 Day Price Move • Nov 23
Market bids up stock over the past week After last week's 33% share price gain to LK₨92.60, the stock is trading at a trailing P/E ratio of 6.8x, up from the previous P/E ratio of 5.1x. This compares to an average P/E of 8x in the Chemicals industry in Sri Lanka. Total returns to shareholders over the past three years are 91%. Valuation Update With 7 Day Price Move • Oct 20
Market bids up stock over the past week After last week's 18% share price gain to LK₨77.00, the stock is trading at a trailing P/E ratio of 5.7x, up from the previous P/E ratio of 4.8x. This compares to an average P/E of 9x in the Chemicals industry in Sri Lanka. Total returns to shareholders over the past three years are 45%. Is New 90 Day High Low • Oct 15
New 90-day high: LK₨76.20 The company is up 62% from its price of LK₨46.90 on 17 July 2020. The Sri Lankan market is up 20% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 76% over the same period. Valuation Update With 7 Day Price Move • Oct 15
Market bids up stock over the past week After last week's 20% share price gain to LK₨76.20, the stock is trading at a trailing P/E ratio of 5.6x, up from the previous P/E ratio of 4.7x. This compares to an average P/E of 7x in the Chemicals industry in Sri Lanka. Total returns to shareholders over the past three years are 45%. Is New 90 Day High Low • Sep 24
New 90-day high: LK₨64.00 The company is up 20% from its price of LK₨53.20 on 26 June 2020. The Sri Lankan market is up 13% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Chemicals industry, which is up 50% over the same period. 
